These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11485664)
21. Protection of human subjects. Time for reassessment. Foley G Cancer Pract; 1999; 7(5):220. PubMed ID: 10687589 [No Abstract] [Full Text] [Related]
22. [Ethics committees: international experience and of the National Institute for cancer research of Genoa]. Sinaccio G; Robert E; Corda A; Dagnino G; Rosmino E; Gipponi M Minerva Med; 1990 Dec; 81(12):869-73. PubMed ID: 2280878 [TBL] [Abstract][Full Text] [Related]
23. Use of human subjects in experimentation. Institutional review boards: purposes, protocols, legal responsibilities. Knepper JD J Am Med Rec Assoc (1980); 1982 Oct; 53(5):97-101. PubMed ID: 10298700 [No Abstract] [Full Text] [Related]
24. Nontherapeutic research on subjects unable to grant consent. Frank S; Agich GJ Clin Res; 1985 Oct; 33(4):459-64. PubMed ID: 4053504 [No Abstract] [Full Text] [Related]
26. [Variation and inconsistency in the evaluation of experiments by medical ethics committees]. Bergkamp L Ned Tijdschr Geneeskd; 1989 Mar; 133(9):446-9. PubMed ID: 2710252 [TBL] [Abstract][Full Text] [Related]
27. The institutional review board: an evolving ethics committee. Lind SE J Clin Ethics; 1992; 3(4):278-82. PubMed ID: 1463879 [No Abstract] [Full Text] [Related]
30. The institutional review board and beyond: future challenges to the ethics of human experimentation. Edgar H; Rothman DJ Milbank Q; 1995; 73(4):489-506. PubMed ID: 7491097 [TBL] [Abstract][Full Text] [Related]
32. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule. Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215 [TBL] [Abstract][Full Text] [Related]
33. Research ethics and new diagnostic technologies. Weber LJ; Bissell MG Clin Lab Manage Rev; 1996; 10(2):182-4. PubMed ID: 10172602 [No Abstract] [Full Text] [Related]
34. Experience with boards and commissions concerned with research ethics in the United States. McCarthy CR Prog Clin Biol Res; 1983; 128():111-22. PubMed ID: 6634724 [No Abstract] [Full Text] [Related]
35. Ethics and human experimentation. Henry Beecher revisited. Rothman DJ N Engl J Med; 1987 Nov; 317(19):1195-9. PubMed ID: 3309660 [No Abstract] [Full Text] [Related]
36. Institutional review boards and the freedom to take risks. Pattullo EL N Engl J Med; 1982 Oct; 307(18):1156-9. PubMed ID: 7121543 [No Abstract] [Full Text] [Related]
37. Is informed consent always necessary for randomized, controlled trials? Carome MA N Engl J Med; 1999 Aug; 341(6):448-9; author reply 450. PubMed ID: 10438260 [No Abstract] [Full Text] [Related]
38. Developing regulations for research involving adults who lack decision-making capacity. Fleischman AR Trans Am Clin Climatol Assoc; 1999; 110():131-43; discussion 143-5. PubMed ID: 10344013 [No Abstract] [Full Text] [Related]
39. Defining and describing benefit appropriately in clinical trials. King NM J Law Med Ethics; 2000; 28(4):332-43. PubMed ID: 11317426 [No Abstract] [Full Text] [Related]
40. Research policy for nursing services: Part 2. Hodgman EC J Nurs Adm; 1981 May; 11(5):33-6. PubMed ID: 6915095 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]